LuciFilgo 100 MG (Filgotinib)

Description

Filgotinib

Each film -coated tablet contains Filgotinib maleate 127.28mg equivalent to Filgotinib … 100 mg.

INDICATION

• Rheumatoid arthritis LuciFilgo is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs). • Ulcerative colitis LuciFilgo is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

DOSAGE AND USE

• Rheumatoid arthritis The recommended dose of filgotinib for adult patients is 200 mg once daily.In adults at increased risk of VTE, MACE and malignancy, the recommended dose is 100 mg once daily and may be escalated to 200 mg once daily in case of insufficient disease control. For long term treatment, the lowest effective dose should be used. • Ulcerative colitis The recommended dose for induction treatment is 200 mg once daily. For patients with ulcerative colitis who do not show an adequate therapeutic benefit during the initial 10 weeks of treatment,12 additional weeks of induction treatment with filgotinib 200 mg once daily may provide additional relief of symptoms.

STORAGE

In a dry place and store at 20°C to 25°C.

MANUFACTURED AND MARKETED BY

LUCIUS PHARMACEUTICALS(LAO) CO., LTD No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos.

WARNING

Keep medicine out of reach of Children. Do not administer LuciFilgo during Pregnancy and Lactation.